Advertisement
UK markets close in 2 hours 10 minutes

  • FTSE 100

    8,336.19
    +22.52 (+0.27%)
     

  • FTSE 250

    20,385.26
    -27.82 (-0.14%)
     

  • AIM

    777.29
    +0.87 (+0.11%)
     

  • GBP/EUR

    1.1606
    -0.0018 (-0.15%)
     

  • GBP/USD

    1.2474
    -0.0036 (-0.29%)
     

  • Bitcoin GBP

    49,809.88
    -1,230.55 (-2.41%)
     

  • CMC Crypto 200

    1,321.02
    +26.35 (+2.03%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CRUDE OIL

    77.88
    -0.50 (-0.64%)
     

  • GOLD FUTURES

    2,322.00
    -2.20 (-0.09%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • DAX

    18,450.50
    +20.45 (+0.11%)
     

  • CAC 40

    8,129.23
    +53.55 (+0.66%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

WHO urges use of blood-derived drugs against Ebola, backs vaccine trials

Reuters - UK Focus

GENEVA, Sept 5 (Reuters) - The World Health Organisation (WHO) said on Friday that experts had agreed that blood-derived drug therapies and convalescent serum may be used for treatment of Ebola virus, and called for investment in the unproven drugs.

Two "promising" Ebola vaccines have also been identified, and safety results from clinical trials may be available this November, paving the way for their use, WHO assistant director-general Marie-Paule Kieny told a news conference.

The two vaccines are made by GlaxoSmithKline Plc (Other OTC: GLAXF - news) and NewLink Genetics, according to WHO documents submitted to the two-day talks attended by nearly 200 experts. "These must be prioritised in terms of clinical development," Kieny said. (Reporting by Stephanie Nebehay and Tom Miles; Editing by Kevin Liffey)